Citation Impact
Citing Papers
Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
2008 Standout
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Retroviral superinfection resistance
2005
Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States
2013
The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity
2011 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges
2006
Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
2011
Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis
2013
COVID-19: A promising cure for the global panic
2020 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Distinct efficacy of HIV-1 entry inhibitors to prevent cell-to-cell transfer of R5 and X4 viruses across a human placental trophoblast barrier in a reconstitution model in vitro
2008 StandoutNobel
Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons
1997
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
2010
HIV Postexposure Prophylaxis Use Among Ontario Female Adolescent Sexual Assault Victims: A Prospective Analysis
2008
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
2004
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?
2006
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
The interaction of HIV with dendritic cells: outcomes and pathways
2007 StandoutNobel
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention
2012
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Sexually transmitted diseases treatment guidelines
2003 Standout
Microbicides for HIV prevention: reality or hope?
2009
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Acute HIV revisited: new opportunities for treatment and prevention
2004
Occupational Exposure to HIV in Health Care Settings
2003
Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection
2015 StandoutNobel
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
2004
A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection
2007
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
2008
Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus
2003
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
HIV as a chronic disease
2009
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
2008
Evaluation of antiretrovirals in animal models of HIV infection
2009
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Acyclic nucleoside phosphonates: Past, present and future
2006
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion
2005 Nature
Validating the vitality strategy for fighting drug resistance
2011 StandoutNobel
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Respiratory Syncytial Viral Infection in Children with Compromised Immune Function
1986
Human Parvovirus B19
2002 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine
2009
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Experimental and Clinical Pharmacology ofAndrographis paniculataand Its Major Bioactive Phytoconstituent Andrographolide
2013 Standout
Severe Anemia Caused by Human Parvovirus in a Leukemia Patient on Maintenance Chemotherapy
1988
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
2006 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Preexposure Prophylaxis for the Prevention of HIV Infection
2019
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
2011
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
2009
Post‐exposure prophylaxis for HIV infection in sexual assault victims
2019
Humanized mouse models of HIV infection.
2011
Works of Eddie Jackson being referenced
Identification of a Window Period for Susceptibility to Dual Infection with Two Distinct Human Immunodeficiency Virus Type 2 Isolates in aMacaca nemestrina(Pig‐tailed Macaque) Model
1999
Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges
2006
Pig‐tailed Macaques Infected with Human Immunodeficiency Virus (HIV) Type 2GB122or Simian/HIV89.6pExpress Virus in Semen during Primary Infection: New Model for Genital Tract Shedding and Transmission
2001
Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman Primates
2004
Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir
2008
Virus infections in children with acute lymphoblastic leukaemia.
1979
Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)
2000